4.36
price up icon11.79%   0.46
 
loading
Neuronetics Inc stock is traded at $4.36, with a volume of 3.03M. It is up +11.79% in the last 24 hours and up +101.85% over the past month. Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
See More
Previous Close:
$3.90
Open:
$4.04
24h Volume:
3.03M
Relative Volume:
2.90
Market Cap:
$277.52M
Revenue:
$69.23M
Net Income/Loss:
$-33.10M
P/E Ratio:
-3.6949
EPS:
-1.18
Net Cash Flow:
$-39.26M
1W Performance:
+42.02%
1M Performance:
+101.85%
6M Performance:
+425.36%
1Y Performance:
+25.29%
1-Day Range:
Value
$3.97
$4.57
1-Week Range:
Value
$3.10
$4.57
52-Week Range:
Value
$0.52
$5.0699

Neuronetics Inc Stock (STIM) Company Profile

Name
Name
Neuronetics Inc
Name
Phone
877-600-7555
Name
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Name
Employee
201
Name
Twitter
@tmstherapy
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
STIM's Discussions on Twitter

Compare STIM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
STIM
Neuronetics Inc
4.36 277.52M 69.23M -33.10M -39.26M -1.18
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
531.85 203.43B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
206.30 148.35B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
134.67 38.42B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
444.53 36.40B 3.90B 887.87M 808.08M 10.67
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
193.44 34.06B 15.41B 1.37B 2.11B 7.50

Neuronetics Inc Stock (STIM) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-13-24 Downgrade William Blair Outperform → Mkt Perform
Oct-13-21 Downgrade BTIG Research Buy → Neutral
Oct-13-21 Downgrade William Blair Outperform → Mkt Perform
Jan-22-21 Upgrade William Blair Mkt Perform → Outperform
Feb-06-20 Initiated BTIG Research Buy
Jul-24-18 Initiated Canaccord Genuity Buy
View All

Neuronetics Inc Stock (STIM) Latest News

pulisher
Feb 16, 2025

Neuronetics CFO Stephen Furlong sells $41,536 in stock - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Savara Inc. Awards Stock Options and RSUs to New Employees - MyChesCo

Feb 16, 2025
pulisher
Feb 15, 2025

Insider Selling: Neuronetics, Inc. (NASDAQ:STIM) CFO Sells 10,845 Shares of Stock - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Neuronetics, Inc. (NASDAQ:STIM) EVP Sells $46,630.25 in Stock - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Neuronetics EVP William Andrew Macan sells $46,630 in stock - MSN

Feb 15, 2025
pulisher
Feb 14, 2025

Neuronetics Executives Sell Shares for Tax Obligations - TradingView

Feb 14, 2025
pulisher
Feb 14, 2025

Neuronetics CFO Stephen Furlong sells shares worth $48,662 - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

Neuronetics CEO Keith Sullivan sells $134,453 in stock - MSN

Feb 14, 2025
pulisher
Feb 13, 2025

Stephen Furlong Sells 14,836 Shares of Neuronetics, Inc. (NASDAQ:STIM) Stock - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Insider Selling: Neuronetics, Inc. (NASDAQ:STIM) CEO Sells 40,992 Shares of Stock - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Neuronetics' EVP William Andrew Macan sells $6,461 in stock - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

Neuronetics’ EVP William Andrew Macan sells $6,461 in stock By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 12, 2025

Neuronetics CEO Keith Sullivan sells $134,453 in stock By Investing.com - Investing.com Australia

Feb 12, 2025
pulisher
Feb 12, 2025

Neuronetics' EVP William Andrew Macan sells $6,461 in stock By Investing.com - Investing.com Canada

Feb 12, 2025
pulisher
Feb 12, 2025

Transcranial Magnetic Stimulator Market Booming Demand, - openPR

Feb 12, 2025
pulisher
Feb 10, 2025

Neuronetics Prices Public Offering of Common Stock at $2.25 Per Share - MSN

Feb 10, 2025
pulisher
Feb 10, 2025

Neuronetics announces inducement grant - Medical Buyer

Feb 10, 2025
pulisher
Feb 10, 2025

STIM’s Debt-to-Equity Ratio at 5.19: What It Means for Neuronetics Inc’s Future - The InvestChronicle

Feb 10, 2025
pulisher
Feb 10, 2025

Ratios Uncovered: Breaking Down Neuronetics Inc (STIM)’s Trailing Twelve Months Metrics - The Dwinnex

Feb 10, 2025
pulisher
Feb 10, 2025

A year in review: Neuronetics Inc (STIM)’s performance in the last year - US Post News

Feb 10, 2025
pulisher
Feb 10, 2025

Neuronetics Inc [STIM] Stock sold by Insider Furlong Stephen for $1122.0 - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Industry Analysts Just Made A Dazzling Upgrade To Their Neuronetics, Inc. (NASDAQ:STIM) Revenue Forecasts - Simply Wall St

Feb 10, 2025
pulisher
Feb 10, 2025

Neuronetics Inc (STIM) Stock: A Closer Look at the Analyst Ratings - The News Heater

Feb 10, 2025
pulisher
Feb 09, 2025

Neuronetics announces public stock offering - MSN

Feb 09, 2025
pulisher
Feb 09, 2025

Neuronetics Announces Stock Awards to New Employees - MSN

Feb 09, 2025
pulisher
Feb 08, 2025

Neuronetics shares drop as it prices $18M public offering of common stock - MSN

Feb 08, 2025
pulisher
Feb 07, 2025

Neuronetics shares fall on launch of public offering of common stock - MSN

Feb 07, 2025
pulisher
Feb 07, 2025

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Feb 07, 2025
pulisher
Feb 07, 2025

Neuronetics Strategic Talent Acquisition: Inside the 15,750 Share RSU Package - StockTitan

Feb 07, 2025
pulisher
Feb 07, 2025

Neuronetics Shares Drop After $18M Offering Priced - MarketWatch

Feb 07, 2025
pulisher
Feb 07, 2025

Neuronetics Prices Eight Million Share Offering at $2.25 Per Share -February 07, 2025 at 08:19 am EST - Marketscreener.com

Feb 07, 2025
pulisher
Feb 07, 2025

Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock - EIN News

Feb 07, 2025
pulisher
Feb 07, 2025

Neuronetics announces public stock offering By Investing.com - Investing.com Canada

Feb 07, 2025
pulisher
Feb 06, 2025

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock - The Manila Times

Feb 06, 2025
pulisher
Feb 06, 2025

Are Smart Investors Making the Right Decision? Neuronetics Inc (STIM) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Medical Transcranial Magnetic Stimulator Market Generated - openPR

Feb 06, 2025
pulisher
Feb 05, 2025

Neuronetics Inc (STIM)’s stock chart: A technical perspective - US Post News

Feb 05, 2025
pulisher
Feb 05, 2025

Market Momentum Report: Neuronetics Inc (STIM)’s Positive Close at 3.45 - The Dwinnex

Feb 05, 2025
pulisher
Feb 04, 2025

Neuronetics Inc (STIM) rating downgrades by William Blair - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Unlocking the Healthcare Boom: Why Neuronetics is a Game-Changer for Investors - Jomfruland.net

Feb 04, 2025
pulisher
Feb 03, 2025

Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 - Insider Monkey

Feb 03, 2025
pulisher
Feb 02, 2025

Short Interest in Neuronetics, Inc. (NASDAQ:STIM) Drops By 35.8% - MarketBeat

Feb 02, 2025

Neuronetics Inc Stock (STIM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research DGX
$168.77
price up icon 0.03%
diagnostics_research LH
$246.49
price up icon 0.66%
$173.39
price up icon 1.56%
diagnostics_research WAT
$369.73
price down icon 2.47%
diagnostics_research MTD
$1,271.91
price down icon 1.95%
diagnostics_research IQV
$193.44
price down icon 1.33%
Cap:     |  Volume (24h):